Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yan-Wen Yao"'
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e55128 (2013)
BackgroundThe aim of this study was to assess the role of skin rash in predicting the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and the prognosis of patients with non-small cell lung cancer (NSCLC).MethodWe s
Externí odkaz:
https://doaj.org/article/98f5613a8b274eb4a0bafbfcb0dafa00
Autor:
Hongbin Liu, Yong Song, Qin Zhang, Qian Li, Xin-Wu Xiao, Yan-Wen Yao, Yan Zhang, Dongmei Yuan, Tangfeng Lv, Yan-Ling Lv
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 17:1661-1675
Objectives: Can addition of neurokinin-1 receptor antagonists (NK1-RAs) be considered as an ideal strategy for the prevention of chemotherapy-induced nausea and vomiting (CINV)? Researchers differ on this question. Materials and Methods: Electronic d
Autor:
Dong-Mei, Yuan, Yan-Ling, Lv, Yan-Wen, Yao, Xiao-Hui, Miao, Qian, Wang, Xin-Wu, Xiao, Jie, Yin, Yi, Shi, Mei-Qi, Shi, Xiu-Wei, Zhang, Yong, Song
Publikováno v:
Thoracic cancer. 3(4)
Abraxane is a novel Cremophor-free nanoparticle paclitaxel that has been demonstrated to improve efficacy in the treatment of solid tumors. We undertook this retrospective study to evaluate the efficacy and safety of Abraxane in the progressive or re
Autor:
Dong-Mei Yuan, Yan-Wen Yao, Xiu-wei Zhang, Mei-qi Shi, Xin-Wu Xiao, Yan-Ling Lv, Yong Song, Yi Shi, Qian Wang, Xiao-hui Miao, Jie Yin
Publikováno v:
Thoracic Cancer. 3:341-347
Background: Abraxane is a novel Cremophor-free nanoparticle paclitaxel that has been demonstrated to improve efficacy in the treatment of solid tumors. We undertook this retrospective study to evaluate the efficacy and safety of Abraxane in the progr
Autor:
Wen, Yang, Yan-Wen, Yao, Jun-Li, Zeng, Wen-Jun, Liang, Li, Wang, Cui-Qing, Bai, Chun-Hua, Liu, Yong, Song
Publikováno v:
Journal of thoracic disease. 6(6)
A number of studies have investigated the relationship between fibroblast growth factor receptor1 (FGFR1) gene copy number and survival in non-small cell lung cancer (NSCLC) patients. However, conclusions reported by different parties seem to be inco
Publikováno v:
Zhonghua yi xue za zhi. 93(38)
To explore the protein-tyrosine-phosphatase 1B (PTP1B) expression and its prognostic significance in non-small-cell lung cancer (NSCLC).Immunohistochemical method of EnVision was applied to investigate the expression of PTP1B in lung specimens from 6
Publikováno v:
Zhonghua yi xue za zhi. 91(40)
To explore the values of low-dose computed tomography (LDCT) in the screening of high-risk populations for early lung cancer through a meta-analysis of the relevant literature.PubMed, EBSCO, Cochrane and other databases were searched with key words.
Autor:
Xiao-Hui, Miao, Yan-Wen, Yao, Dong-Mei, Yuan, Yan-Ling, Lv, Ping, Zhan, Tang-Feng, Lv, Hong-Bing, Liu, Yong, Song
Publikováno v:
Journal of thoracic disease. 4(3)
Lung cancer is the leading cause of cancer-associated death. In many countries, adenocarcinoma is the most common histologic type in lung cancer. Previously, few factors are identified to be prognostic indicators for the patients with small lung aden
Autor:
Dong-Mei, Yuan, Yan-Ling, Lü, Yan-Wen, Yao, Hong-Bing, Liu, Qian, Wang, Xin-Wu, Xiao, E-Hong, Cao, Yi, Shi, Xiao-Jun, Zhou, Yong, Song
Publikováno v:
Chinese medical journal. 124(20)
Computed tomography (CT)-guided transthoracic lung biopsy is a well-established technique for the diagnosis of pulmonary lesions. The objective of this study was to evaluate the diagnostic efficiency and complication rate of CT-guided lung biopsy in
Publikováno v:
2015 IEEE International Conference on Computer & Information Technology; Ubiquitous Computing & Communications; Dependable, Autonomic & Secure Computing; Pervasive Intelligence & Computing; 2015, p1942-1947, 6p